UBS Group’s Lixte Biotechnology Warrants LIXTW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $125 | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $245 | Buy |
|
|||||
|
2024
Q1 | $193 | Buy |
|
|||||
|
2023
Q4 | $8 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $70 | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $0 | Buy |
|
|||||
|
2022
Q2 | $1K | Sell |
|
|||||
|
2022
Q1 | $2K | Buy |
|
|||||
|
2021
Q4 | $3K | Sell |
|
|||||
|
2021
Q3 | $5K | Sell |
|
|||||
|
2021
Q2 | $7K | Buy |
|
|||||
|
2021
Q1 | $6K | Sell |
|
|||||
|
2020
Q4 | $21K | Buy |
|